Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
critical limb ischemia
Biotech
Ixaka's cell therapy clears interim phase 3 data review
Ixaka said the analysis “is consistent with the effect observed in previous clinical trials" that linked the cells to a 70% complete response rate.
Nick Paul Taylor
Sep 10, 2021 11:05am
NASA-partnered Pluristem crashes to Earth
Dec 10, 2020 7:25am
Profusa's wireless, injectable oxygen biosensor nabs CE mark
Jan 29, 2020 11:20am
LimFlow bags $34M to trial limb-saving artery disease device
Apr 18, 2018 10:13am
3D-printed patch grows healthy mouse blood vessels, could treat ischemia
Jun 16, 2017 11:14am